As a subtype of breast cancer, Triple-negative breast cancer (TNBC) is negative for expression of progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER-2), and accounts for 10% to 20% of all breast cancer cases2. This evidence concerns the gene PGR and triple-negative breast carcinoma.